About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,497 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,497 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3761-3780 of 7,497 trials

UnknownExploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate CancerProstate cancer is the most common cancer in males in the UK, and current estimates are that 1 in 8 will be diagnosed with prostate cancer in their lifetime.NCT04686188·Sutton, Surrey

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedHypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical ProstatectomyThis phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk features following radical prostatectomy.NCT03570827·Scottsdale, Arizona and 1 other

RecruitingThe Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical ProstatectomyThis prospective randomized controlled study aims to evaluate the effect of mobile-based perioperative education on postoperative urinary incontinence and erectile function in…NCT07520916·Giresun, Giresun

CompletedZoledronate and BMS-275291 in Treating Patients With Prostate CancerPhase II trial to study the effectiveness of combining zoledronate with BMS-275291 in treating patients who have prostate cancer that has not responded to previous hormone therapy.NCT00039104·Rochester, Minnesota

CompletedSingle Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate CancerObjectives to evaluate the activity of Erlotinib in prostate cancer patients who are hormone refractory and androgen independent and have not been exposed to chemotherapy.NCT00272038·Park Ridge, Illinois

RecruitingPRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate CancerPRO-BOOST-LC is a prospective, multicenter, randomized phase II/III clinical trial for men with localized or locally advanced prostate cancer without lymph node or distant…NCT07426055·Zamość, Lublin Voivodeship

RecruitingPhase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)In advanced metastatic castration resistant prostate cancer (mCRPC) progressing after chemotherapy and androgen receptor (AR)-targeted therapy 177Lu-PSMA-617 is an effective…NCT06216249·Los Angeles, California

CompletedComparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.The objective of this study is to compare the efficacy and safety of enzalutamide or alternative AA therapy in CRPC participants who were previously treated with a combined…NCT02346578·Osaka

CompletedFluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the BoneThis trial studies how well fluciclovine 18F PET/CT imaging works in assessing hormone-naive men with prostate cancer that has spread to the bone.NCT03707184·Salt Lake City, Utah

CompletedDolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003626·Denver, Colorado and 2 others

Active not recruitingPhase Ia/Ib Talazoparib + Tazemetostat for mCRPCThis trial is testing whether molecularly targeted oral medications called talazoparib and tazemetostat can be safely combined for the treatment of prostate cancer, and whether…NCT04846478·Boston, Massachusetts and 1 other

UnknownOsteoporosis Among Men Treated With Androgen Deprivation for Prostate CancerThe purpose of this study is * to determine the rate of osteoporosis among patients with advanced prostate cancer.NCT00957606·Odense and 1 other

Active not recruitingIntelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal DataThis project aims to develop a precision screening and diagnostic solution for prostate cancer based on multimodal artificial intelligence, focusing on addressing the diagnostic…NCT07631806·Nan'ning, Guangxi

CompletedFeasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate CancerPURPOSE: To evaluate the feasibility of a future Nordic intervention trial, including vigorous activity and a high intake of whole grain rye, among prostate cancer patients on…NCT01300104·Aarhus and 3 others

TerminatedProstate Cancer VaccinesTumor antigens are protein fragments produced by cancer cells carrying genetic mutations, and many tumor antigens are similar to normal protein antigens, making them…NCT07068555·Shenzhen, Guangdong

Not yet recruitingEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerThe objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic…NCT07781852·Boston, Massachusetts and 2 others

CompletedStudy of Dose Escalation of Abiraterone Actetate in Prostate CancerThe purpose of this study is to test whether a dose escalation up to 2000 mg per day of abiraterone acetate is feasible and lead to disease stabilization in castration-resistant…NCT03458247·Paris, Paris

TerminatedA Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyThe purpose of this study is to confirm that tasquinimod used as maintenance therapy is active and tolerable in patients with metastatic castrate-resistant prostate cancer not…NCT01732549·Ghent and 57 others

CompletedMolecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26The study should evaluate the biological distribution of 99mTc-RM26 in patients with prostate cancer and breast cancer. The primary objective are: 1.NCT04746638·Tomsk

Approved for marketing18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerThe purpose of this research study is to see if patients' tumor can be identified by 18F-DCFPyL PET/MRI scan.NCT04809584·Stanford, California

PreviousPage 189 of 375Next